The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome
- PMID: 23654327
- DOI: 10.3109/01443615.2013.771159
The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome
Abstract
The national registration and treatment service for molar pregnancies in the UK allows for the collection of accurate data on this relatively rare diagnosis. In England and Wales, between 2000 and 2009, 5,793 patients with complete moles and 7,790 with partial moles were registered, compared with a total of 8,242,511 conceptions. The overall molar pregnancy incidence was 1 for every 607 conceptions (complete mole 1:1,423; partial mole 1:1,058), but with major variations with age. For complete moles, the risk varied from < 1:1,000 for ages 18-40, to 1:156 for women aged 45 and 1:8 for those aged 50 and above. The overall risk of requiring chemotherapy after a complete mole was 13.6% and 1.1% for partial mole, while the risk of a further molar pregnancy in the next conception was 1:68 but each of these figures have considerable variations with age. These modern statistics on molar pregnancy risks and outcomes should be of value to clinicians and their patients, while discussing this rare diagnosis.
Similar articles
-
Characteristics of women with recurrent molar pregnancies.Gynecol Oncol. 2000 Sep;78(3 Pt 1):288-92. doi: 10.1006/gyno.2000.5871. Gynecol Oncol. 2000. PMID: 10985882
-
The demographics of molar pregnancies in England and Wales from 2000-2009.J Reprod Med. 2010 Jul-Aug;55(7-8):341-5. J Reprod Med. 2010. PMID: 20795349
-
Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.BJOG. 2003 Jan;110(1):22-6. BJOG. 2003. PMID: 12504931
-
Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center.J Reprod Med. 2014 May-Jun;59(5-6):188-94. J Reprod Med. 2014. PMID: 24937955 Review.
-
Epidemiology of hydatidiform mole and choriocarcinoma.Epidemiol Rev. 1984;6:52-75. doi: 10.1093/oxfordjournals.epirev.a036275. Epidemiol Rev. 1984. PMID: 6386504 Review.
Cited by
-
Parental contribution to trisomy in heterozygous androgenetic complete moles.Sci Rep. 2020 Oct 13;10(1):17137. doi: 10.1038/s41598-020-74375-4. Sci Rep. 2020. PMID: 33051545 Free PMC article.
-
Advances in the diagnosis and early management of gestational trophoblastic disease.BMJ Med. 2022 Dec 16;1(1):e000321. doi: 10.1136/bmjmed-2022-000321. eCollection 2022. BMJ Med. 2022. PMID: 36936581 Free PMC article. Review.
-
The hydatidiform mole.Cell Adh Migr. 2016 Mar 3;10(1-2):226-35. doi: 10.1080/19336918.2015.1093275. Epub 2015 Sep 30. Cell Adh Migr. 2016. PMID: 26421650 Free PMC article. Review.
-
Clinical Features of Gestational Trophoblastic Disease in Aged Women in South Vietnam.Yonsei Med J. 2023 Apr;64(4):284-290. doi: 10.3349/ymj.2022.0241. Yonsei Med J. 2023. PMID: 36996900 Free PMC article.
-
Placental mesenchymal dysplasia: A rare case report and literature review.Medicine (Baltimore). 2025 Jun 6;104(23):e42663. doi: 10.1097/MD.0000000000042663. Medicine (Baltimore). 2025. PMID: 40489861 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical